Upregulation of MG53 Induces Diabetic Cardiomyopathy Through Transcriptional Activation of Peroxisome Proliferation-Activated Receptor α
Author(s) -
Fenghua Liu,
Ruisheng Song,
Yuanqing Feng,
Jiaojiao Guo,
Yanmin Chen,
Yong Zhang,
Tao Chen,
Yanru Wang,
Yanyi Huang,
ChuanYun Li,
Chunmei Cao,
Yan Zhang,
Xinli Hu,
RuiPing Xiao
Publication year - 2015
Publication title -
circulation
Language(s) - English
Resource type - Journals
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.114.012285
Subject(s) - downregulation and upregulation , medicine , diabetic cardiomyopathy , peroxisome proliferator activated receptor , cardiomyopathy , receptor , microbiology and biotechnology , peroxisome proliferator activated receptor gamma , peroxisome , diabetes mellitus , cancer research , endocrinology , heart failure , gene , biochemistry , biology
Diabetic cardiomyopathy, which contributes to >50% diabetic death, is featured by myocardial lipid accumulation, hypertrophy, fibrosis, and cardiac dysfunction. The mechanism underlying diabetic cardiomyopathy is poorly understood. Recent studies have shown that a striated muscle-specific E3 ligase Mitsugumin 53 (MG53, or TRIM72) constitutes a primary causal factor of systemic insulin resistance and metabolic disorders. Although it is most abundantly expressed in myocardium, the biological and pathological roles of MG53 in triggering cardiac metabolic disorders remain elusive.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom